Search Results

​
search
Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate
February 19, 2025 13:29 ET | Radiance BioPharma
BOSTON, Massachusetts, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or the "Company"), a biotechnology company, today announced that it has entered into an exclusive...